 |
Amgen
AMGN
|
25.7 |
$ 350.13 |
2.98 % |
$ 188 B |
USA |
 |
MorphoSys AG
MOR
|
-0.612 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Acorda Therapeutics
ACOR
|
-0.0662 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
-0.583 |
- |
- |
$ 86.2 M |
USA |
 |
Amneal Pharmaceuticals
AMRX
|
59.8 |
$ 12.73 |
3.33 % |
$ 3.99 B |
USA |
 |
AlloVir
ALVR
|
-0.189 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Applied Molecular Transport
AMTI
|
-0.175 |
- |
- |
$ 10.1 M |
USA |
 |
argenx SE
ARGX
|
-33.7 |
$ 783.17 |
2.32 % |
$ 25 B |
Niderland |
 |
Autolus Therapeutics plc
AUTL
|
-1.12 |
$ 1.48 |
8.82 % |
$ 394 M |
Britain |
 |
Applied Therapeutics
APLT
|
-4.52 |
- |
- |
$ 8.42 M |
USA |
 |
I-Mab
IMAB
|
-0.236 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
2.49 K |
- |
2.54 % |
$ 160 B |
France |
 |
Arcutis Biotherapeutics
ARQT
|
-213 |
$ 24.57 |
5.59 % |
$ 3.13 B |
USA |
 |
Biophytis SA
BPTS
|
-17.6 |
- |
-13.47 % |
$ 169 M |
France |
 |
AVROBIO
AVRO
|
4.63 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.203 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
706 |
- |
- |
$ 96.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
-14.5 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BioNTech SE
BNTX
|
6.11 |
$ 91.64 |
2.25 % |
$ 27.2 B |
Germany |
 |
BeiGene, Ltd.
BGNE
|
-392 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-66.5 |
$ 3.82 |
1.6 % |
$ 9.19 B |
Australia |
 |
Burford Capital Limited
BUR
|
12.2 |
$ 4.62 |
1.54 % |
$ 742 M |
Britain |
 |
Advaxis
ADXS
|
-0.0388 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aytu BioScience
AYTU
|
-1.16 |
$ 2.68 |
4.28 % |
$ 16.8 M |
USA |
 |
Avid Bioservices
CDMO
|
-3.01 |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
-0.873 |
- |
- |
$ 1.41 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-400 |
$ 3.05 |
0.66 % |
$ 6.64 B |
Israel |
 |
Институт стволовых клеток человека
ISKJ
|
38.8 |
- |
- |
- |
Russia |
 |
Cabaletta Bio
CABA
|
-1.69 |
$ 3.05 |
-0.5 % |
$ 306 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
-2.85 |
- |
- |
$ 169 M |
USA |
 |
Aeterna Zentaris
AEZS
|
-4.94 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.859 |
- |
- |
$ 231 M |
USA |
 |
Cerus Corporation
CERS
|
-31.7 |
$ 1.93 |
4.62 % |
$ 368 M |
USA |
 |
AgeX Therapeutics
AGE
|
-0.00095 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
-1.29 |
- |
- |
$ 401 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-3.48 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-1.71 |
- |
- |
$ 26.5 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
-5.92 |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
-1.33 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
-0.0913 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.00975 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Cellectar Biosciences
CLRB
|
-0.344 |
$ 2.83 |
2.91 % |
$ 7.38 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-6.15 |
- |
- |
$ 2.18 B |
USA |
 |
Akero Therapeutics
AKRO
|
-12.9 |
- |
- |
$ 3.67 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
63.3 |
- |
- |
$ 2.02 B |
USA |
 |
CureVac N.V.
CVAC
|
-8.58 |
- |
- |
$ 867 M |
Germany |
 |
Coherus BioSciences
CHRS
|
1.35 |
$ 1.73 |
3.59 % |
$ 203 M |
USA |